Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA037395-15
Application #
2089333
Study Section
Special Emphasis Panel (NSS)
Project Start
1983-01-01
Project End
2000-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
15
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Coussens, L M; Tinkle, C L; Hanahan, D et al. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-90
Zhao, H; Bojanowski, K; Ingber, D E et al. (1999) New role for tRNA and its fragment purified from human urinary bladder carcinoma conditioned medium: inhibition of endothelial cell growth. J Cell Biochem 76:109-17
O'Reilly, M S; Brem, H; Folkman, J (1995) Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470. J Pediatr Surg 30:325-9;discussion 329-30
Nguyen, M; Shing, Y; Folkman, J (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47:31-40
Nguyen, M; Watanabe, H; Budson, A E et al. (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86:356-61
Li, V W; Folkerth, R D; Watanabe, H et al. (1994) Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344:82-6
Nguyen, M; Watanabe, H; Budson, A E et al. (1993) Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst 85:241-2
Brem, H; Gresser, I; Grosfeld, J et al. (1993) The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 28:1253-7
Folkman, J; Szabo, S; Stovroff, M et al. (1991) Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 214:414-25;discussion 426-7
Li, W W; Grayson, G; Folkman, J et al. (1991) Sustained-release endotoxin. A model for inducing corneal neovascularization. Invest Ophthalmol Vis Sci 32:2906-11

Showing the most recent 10 out of 17 publications